Opinion

Video

Examining the 505(b)(2) Pathway and Implementation into EHR

A panelist discusses how the 505(b)(2) regulatory pathway provides a streamlined approval process for modified versions of previously approved drugs, allowing pharmaceutical companies to rely partly on existing safety/efficacy data while still requiring new clinical data, commonly used across various therapeutic areas including reformulations, new dosage forms, and drug combinations.

1:14 505(b)(2) Pathway Introduction

6:33 Role of Pharmacists

11:48 505(b)(2) in Oncology

26:00 Medication Management

32:34 Leveraging EHR

44:24 Unmet Needs

Related Videos
5 experts in this video
5 experts in this video
5 experts in this video
5 experts in this video
5 experts in this video
5 experts in this video
5 experts in this video
5 experts in this video
5 experts in this video
5 experts in this video